Skip to main content

Advertisement

Log in

Childhood interstitial lung disease in Turkey: first data from the national registry

  • RESEARCH
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The childhood interstitial lung diseases (chILD) Turkey registry (chILD-TR) was established in November 2021 to increase awareness of disease, and in collaboration with the centers to improve the diagnostic and treatment standards. Here, the first results of the chILD registry system were presented. In this prospective cohort study, data were collected using a data‐entry software system. The demographic characteristics, clinical, laboratory, radiologic findings, diagnoses, and treatment characteristics of the patients were evaluated. Clinical characteristics were compared between two main chILD groups ((A) diffuse parenchymal lung diseases (DPLD) disorders manifesting primarily in infancy [group1] and (B) DPLD disorders occurring at all ages [group 2]). There were 416 patients registered from 19 centers. Forty-six patients were excluded due to missing information. The median age of diagnosis of the patients was 6.05 (1.3–11.6) years. Across the study population (n = 370), 81 (21.8%) were in group 1, and 289 (78.1%) were in group 2. The median weight z-score was significantly lower in group 1 (− 2.0 [− 3.36 to − 0.81]) than in group 2 (− 0.80 [− 1.7 to 0.20]) (p < 0.001). When we compared the groups according to chest CT findings, ground-glass opacities were significantly more common in group 1, and nodular opacities, bronchiectasis, mosaic perfusion, and mediastinal lymphadenopathy were significantly more common in group 2. Out of the overall study population, 67.8% were undergoing some form of treatment. The use of oral steroids was significantly higher in group 2 than in group 1 (40.6% vs. 23.3%, respectively; p = 0.040).

  Conclusion: This study showed that national registry allowed to obtain information about the frequency, types, and treatment methods of chILD in Turkey and helped to see the difficulties in the diagnosis and management of these patients.

What is Known:

• Childhood interstitial lung diseases comprise many diverse entities which are challenging to diagnose and manage.

What is New:

• This study showed that national registry allowed to obtain information about the frequency, types and treatment methods of chILD in Turkey and helped to see the difficulties in the diagnosis and management of these patients. Also, our findings reveal that nutrition should be considered in all patients with chILD, especially in A-DPLD disorders manifesting primarily in infancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Abbreviations

BAL:

Bronchoalveolar lavage

ChILD:

Childhood interstitial lung diseases

ChILD-TR:

ChILD registry system in Turkey

CT:

Computed tomography

DLCOadj:

Adjusted diffusion capacity for carbon monoxide

DPLD:

Diffuse parenchymal lung disease

GERD:

Gastroesophageal reflux disease

FVC:

Forced vital capacity

FEV1:

Forced expiratory volume in 1 s

NEHI:

Neuroendocrine cell hyperplasia of infancy

TLC:

Total lung capacity

WLL:

Whole-lung lavage

References

  1. Nayir Buyuksahin H, Kiper N (2023) Childhood interstitial lung disease. Pediatr Allergy Immunol Pulmonol 36:5–15

    Article  PubMed  Google Scholar 

  2. Griese M (2022) Etiologic classification of diffuse parenchymal (interstitial) lung diseases. J Clin Med 11

  3. Cinel G, Kiper N, Orhan D, Emiralioglu N, Yalcin E, Dogru D, Ozcelik U, Oguz B, Haliloglu M (2020) Childhood diffuse parenchymal lung diseases: we need a new classification. Clin Respir J 14:102–108

    Article  PubMed  Google Scholar 

  4. Rice A, Tran-Dang MA, Bush A, Nicholson AG (2013) Diffuse lung disease in infancy and childhood: expanding the chILD classification. Histopathology 63:743–755

    Article  PubMed  Google Scholar 

  5. Kurland G, Deterding RR, Hagood JS, Young LR, Brody AS, Castile RG, Dell S, Fan LL, Hamvas A, Hilman BC, Langston C, Nogee LM, Redding GJ (2013) An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med 188:376–394

    Article  PubMed  PubMed Central  Google Scholar 

  6. Clement A, Nathan N, Epaud R, Fauroux B, Corvol H (2010) Interstitial lung diseases in children. Orphanet J Rare Dis 5:22

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ferraro VA, Zanconato S, Zamunaro A, Carraro S (2020) Children's interstitial and diffuse lung diseases (ChILD) in 2020. Children (Basel) 7

  8. (2014) AHRQ Methods for Effective Health Care. In: Gliklich RE, Dreyer NA, Leavy MB (eds) Registries for evaluating patient outcomes: a user's guide. Agency for Healthcare Research and Quality (US), Rockville (MD)

  9. Griese M, Seidl E, Hengst M, Reu S, Rock H, Anthony G, Kiper N et al (2018) International management platform for children’s interstitial lung disease (chILD-EU). Thorax 73:231–239

    Article  PubMed  Google Scholar 

  10. Bush A, Cunningham S, de Blic J, Barbato A, Clement A, Epaud R, Hengst M, Kiper N, Nicholson AG, Wetzke M, Snijders D, Schwerk N, Griese M (2015) European protocols for the diagnosis and initial treatment of interstitial lung disease in children. Thorax 70:1078–1084

    Article  PubMed  Google Scholar 

  11. Clement A, de Blic J, Epaud R, Galeron L, Nathan N, Hadchouel A, Barbato A, Snijders D, Kiper N, Cunningham S, Griese M, Bush A, Schwerk N (2016) Management of children with interstitial lung diseases: the difficult issue of acute exacerbations. Eur Respir J 48:1559–1563

    Article  PubMed  Google Scholar 

  12. Seidl E, Schwerk N, Carlens J, Wetzke M, Cunningham S, Emiralioğlu N, Kiper N, Lange J, Krenke K, Ullmann N, Krikovszky D, Maqhuzu P, Griese CA, Schwarzkopf L, Griese M (2022) Healthcare resource utilisation and medical costs for children with interstitial lung diseases (chILD) in Europe. Thorax 77:781–789

    Article  PubMed  Google Scholar 

  13. Griese M, Kappler M, Stehling F, Schulze J, Baden W, Koerner-Rettberg C, Carlens J, Prenzel F, Nährlich L, Thalmeier A, Sebah D, Kronfeld K, Rock H, Ruckes C, Wetzke M, Seidl E, Schwerk N (2022) Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease. Orphanet J Rare Dis 17:289

    Article  PubMed  PubMed Central  Google Scholar 

  14. Casey AM, Deterding RR, Young LR, Fishman MP, Fiorino EK, Liptzin DR (2020) Overview of the ChILD Research Network: a roadmap for progress and success in defining rare diseases. Pediatr Pulmonol 55:1819–1827

    Article  PubMed  Google Scholar 

  15. McKnight L, Schultz A, Vidic N, Palmer EE, Jaffe A (2023) Learning to make a difference for chILD: value creation through network collaboration and team science. Pediatr Pulmonol

  16. Nevel RJ, Deutsch GH, Craven D, Deterding R, Fishman MP, Wambach JA, Casey A et al (2023) The US national registry for childhood interstitial and diffuse lung disease: report of study design and initial enrollment cohort. Pediatr Pulmonol

  17. Kiper N, Emiralioglu N. Nutrition booklet for families of patients with chILD. Available from: www.klinikum.uni-muenchen.de/Child-EU. [Last accessed: January 6, 2020]

  18. Comes A, Wong AW, Fisher JH, Morisset J, Johannson KA, Farrand E, Fell CD, Kolb M, Manganas H, Cox G, Gershon AS, Halayko AJ, Hambly N, Khalil N, Sadatsafavi M, Shapera S, To T, Wilcox PG, Collard HR, Ryerson CJ (2022) Association of BMI and change in weight with mortality in patients with fibrotic interstitial lung disease. Chest 161:1320–1329

    Article  PubMed  Google Scholar 

  19. Rinaldi S, Gilliland J, O’Connor C, Seabrook JA, Mura M, Madill J (2021) Fat-free mass index controlled for age and sex and malnutrition are predictors of survival in interstitial lung disease. Respiration 100:379–386

    Article  PubMed  Google Scholar 

  20. Gilbert C, Bush A, Cunningham S (2015) Childhood interstitial lung disease: family experiences. Pediatr Pulmonol 50:1301–1303

    Article  PubMed  Google Scholar 

  21. Stubbs KH, McMahon MXH, Popler J, Berry RC, Sharp WG (2022) Multidisciplinary feeding treatment for a patient with interstitial lung disease. Pediatr Pulmonol 57:3183–3185

    Article  PubMed  Google Scholar 

  22. Ghisa M, Marinelli C, Savarino V, Savarino E (2019) Idiopathic pulmonary fibrosis and GERD: links and risks. Ther Clin Risk Manag 15:1081–1093

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Dziekiewicz M, Marczak H, Banasiuk M, Aksionchyk M, Krenke K, Banaszkiewicz A (2023) Characteristics of gastroesophageal reflux disease in children with interstitial lung disease. Pediatr Pulmonol 58:171–177

    Article  PubMed  Google Scholar 

  24. Nathan N, Griese M, Michel K, Carlens J, Gilbert C, Emiralioglu N, Torrent-Vernetta A, Marczak H, Willemse B, Delestrain C, Epaud R (2023) Diagnostic workup of childhood interstitial lung disease. Eur Respir Rev 32

  25. Griese M, Schwerk N, Carlens J, Wetzke M, Emiralioğlu N, Kiper N, Lange J, Krenke K, Seidl E (2023) Minimal important difference in childhood interstitial lung diseases. Thorax 78:476–483

    Article  PubMed  Google Scholar 

  26. Ring AM, Carlens J, Bush A, Castillo-Corullón S, Fasola S, Gaboli MP, Griese M, Koucky V, La Grutta S, Lombardi E, Proesmans M, Schwerk N, Snijders D, Nielsen KG, Buchvald F (2020) Pulmonary function testing in children's interstitial lung disease. Eur Respir Rev 29

  27. Spagnolo P, Bush A (2016) Interstitial lung disease in children younger than 2 years. Pediatr 137

  28. Verma N, Altmayer S, Hochhegger B, Barros MC, Rajderkar D, Mohammed TL (2021) ChILD: a pictorial review of pulmonary imaging findings in childhood interstitial lung diseases. Curr Probl Diagn Radiol 50:95–103

    Article  PubMed  Google Scholar 

  29. Liang TI, Lee EY (2020) Interstitial lung diseases in children, adolescents, and young adults: different from infants and older adults. Radiol Clin North Am 58:487–502

    Article  PubMed  Google Scholar 

  30. Nayir Buyuksahin H, Basaran O, Balık Z, Bilginer Y, Ozen S, Dogru D (2023) Interstitial lung disease in autoinflammatory disease in childhood: a systematic review of the literature. Pediatr Pulmonol 58:367–373

    Article  PubMed  Google Scholar 

  31. Doğru D, Yalçin E, Aslan AT, Ocal T, Ozçelik U, Güçer S, Kale G, Haliloglu M, Kiper N (2009) Successful unilateral partial lung lavage in a child with pulmonary alveolar proteinosis. J Clin Anesth 21:127–130

    Article  PubMed  Google Scholar 

  32. Emiralioglu N, Beken B, Ozcan HN, Yalcin E, Dogru D, Ozcelik U, Haliloglu M, Kiper N (2016) Diagnosis and treatment of pulmonary alveolar microlithiasis. Pediatr Int 58:805–807

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all the families and patients for their participation. We thank all the chILD-TR collaborators.

Funding

This project was funded by Hacettepe University Scientific Research Project Coordination Department (Project number: TOA-2021–19075).

Author information

Authors and Affiliations

Authors

Contributions

H.N.B., N.E., and N.K. wrote the main manuscript text. All authors contributed data and reviewed the manuscript.

Corresponding author

Correspondence to Halime Nayır-Büyükşahin.

Ethics declarations

Ethics approval

The establishment of the national registry and data input was approved by the local ethics committee (Hacettepe University Ethics Board, reference numbers: GO 20/604), in addition to the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Competing interests

The authors declare no competing interests.

Additional information

Communicated by Peter de Winter

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nayır-Büyükşahin, H., Emiralioğlu, N., Kılınç, A.A. et al. Childhood interstitial lung disease in Turkey: first data from the national registry. Eur J Pediatr 183, 295–304 (2024). https://doi.org/10.1007/s00431-023-05290-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-023-05290-9

Keywords

Navigation